These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12223313)

  • 1. The role of PPARs in atherosclerosis.
    Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
    Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.
    Elangbam CS; Tyler RD; Lightfoot RM
    Toxicol Pathol; 2001; 29(2):224-31. PubMed ID: 11421489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
    Fruchart JC; Duriez P; Staels B
    Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARS in inflammation, atherosclerosis and thrombosis.
    Duez H; Fruchart JC; Staels B
    J Cardiovasc Risk; 2001 Aug; 8(4):187-94. PubMed ID: 11550996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
    Pineda Torra I; Gervois P; Staels B
    Curr Opin Lipidol; 1999 Apr; 10(2):151-9. PubMed ID: 10327283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
    Neve BP; Fruchart JC; Staels B
    Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
    Chinetti G; Fruchart JC; Staels B
    Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atherosclerotic regression in the aortas of elderly. (4). Expression of peroxisome proliferator-activated receptors with references of centrally depressed atherosclerotic plaque].
    Yamada T; Sueyoshi S; Ohni S; Oinuma T; Mitsumata M; Watanabe H; Matsumoto T; Ueno T; Fujioka T; Kannmatsuse K
    Nihon Ronen Igakkai Zasshi; 2004 Jan; 41(1):105-11. PubMed ID: 14999925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
    Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
    Puddu P; Puddu GM; Muscari A
    Int J Cardiol; 2003 Aug; 90(2-3):133-40. PubMed ID: 12957742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
    Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphan nuclear receptors find a home in the arterial wall.
    Laffitte BA; Tontonoz P
    Curr Atheroscler Rep; 2002 May; 4(3):213-21. PubMed ID: 11931719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis.
    Li AC; Glass CK
    J Lipid Res; 2004 Dec; 45(12):2161-73. PubMed ID: 15489539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice.
    Torra IP; Chinetti G; Duval C; Fruchart JC; Staels B
    Curr Opin Lipidol; 2001 Jun; 12(3):245-54. PubMed ID: 11353326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.